Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001640334-25-000018
Filing Date
2025-01-06
Accepted
2025-01-06 14:57:37
Documents
6
Effectiveness Date
2025-01-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 lxrp_s8.htm S-8 152659
2 OPINION OF SICHENZIA lxrp_ex51.htm EX-5.1 6200
3 CONSENT OF MALONEBAILEY, LLP lxrp_ex232.htm EX-23.2 2072
4 FEE TABLE lxrp_ex107.htm EX-FILING FEES 15479
5 lxrp_s8img2.jpg GRAPHIC 7050
6 lxrp_s8img1.jpg GRAPHIC 14392
  Complete submission text file 0001640334-25-000018.txt   207389
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-8 | Act: 33 | File No.: 333-284144 | Film No.: 25510636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)